Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V68622 | Rhodamine B isothiocyanate (Rhodamine B isothiocyanate) | 36877-69-7 | Rhodamine B isothiocyanate (RBITC) is a fluorescent dye widely used in bioimaging and labeling applications. |
![]() |
V66184 | Ribonucleic acid (RNA) | 63231-63-0 | Ribonucleic acid is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V66842 | Ribose-5-phosphate barium salt (D-ribose-5-phosphate barium salt) | 15673-79-7 | Ribose-5-phosphate Barium Salt is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V86277 | RL-6-Me-7-OH | 2184-54-5 | |
![]() |
V65667 | Rochelle salt (L-Tartaric acid potassium sodium salt tetrahydrate; Potassium sodium tartrate tetrahydrate; Sodium potassium tartrate tetrahydrate) | 6381-59-5 | Rochelle potassium sodium tartrate is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V66118 | ROS tracer precursor | 2153480-20-5 | ROS tracer precursor is the precursor of [18F] ROStrace, which is used to synthesize ROStrace and can be used for disease diagnosis. |
![]() |
V82321 | Rostratin B | 752236-17-2 | Rostratin B is a cytotoxic disulfide with in vitro cytotoxic effect against human colon cancer (HCT-116) with IC50 of 1.9 μg/mL. |
![]() |
V65776 | Ru(dpp)3(PF6)2 | 123148-15-2 | Ru(dpp)3(PF6)2 is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V65170 | RuCl(p-cymene)[(R,R)-Ts-DPEN] (RuCl[(R,R)-Tsdpen](p-cymene)) | 192139-92-7 | RuCl(p-cymene)[(R,R)-Ts-DPEN] is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V68711 | RuPhos | 787618-22-8 | RuPhos is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V65910 | Rutinose (rutin sugar) | 90-74-4 | Rutinose is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V66830 | Rutinose Heptaacetate | 29202-64-0 | Rutinose Heptaacetate is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V65809 | S-(3)-Hydroxymyristic acid, methyl ester | 76835-67-1 | S-(3)-Hydroxymyristic Acid, Methyl Ester is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V65480 | S-EIT hydrobromide (S-Ethylisothiourea hydrobromide) | 1071-37-0 | S-EIT (HBr) is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V66598 | Safflower oil (from Carthamus tinctorius seed) (Safflower seed oil (from Carthamus tinctorius seed)) | 8001-23-8 | Safflower seed oil from Carthamus tinctorius seed is a biochemical compound that could be utilized as a biomaterial or organic/chemical reagent for biomedical research. |
![]() |
V85926 | Salmonella Arizona Agar (SA) | ||
![]() |
V85908 | Salmonella-Shigella Agar (SS Agar) | ||
![]() |
V67072 | SAMe-1,4-Butanedisulfonate (1,4-butanedisulfonate S-adenosylmethionine) | 101020-79-5 | SAMe-1,4-Butanedisulfonat, a natural compound, is a methyl donor to the central nervous system/CNS. |
![]() |
V14372 | SATA Protein Modifier | 76931-93-6 | SATA Protein Modifier, or N-Succinimidyl S-Acetylthioacetate, is a protein modification reagent used to convert primary amine groups into protected sulfhydryls (thiol; -SH) for later reaction with sulfhydryl reactive crosslinkers such as Sulfo-SMCC, Sulfo-MBS, etc. |
![]() |
V3041 | SBE-β-CD (captisol) | 182410-00-0 | SBE-β-CD, also named as Sulfobutylether beta-cyclodextrin or Captisol, is a highly water-soluble anionic derivative of cyclodextrin that is widely used as an excipient or a formulating agent to increase the solubility of poorly soluble drugs. |